首页> 外国专利> A method for the production of steroid - 17beta - sulfo acetate - esters of androstan - and oestranreihe

A method for the production of steroid - 17beta - sulfo acetate - esters of androstan - and oestranreihe

机译:一种生产甾族化合物-17β-乙酸磺基酯-雄烷酸酯-和oestranreihe的方法

摘要

The invention comprises compounds of the formula FORM:1016372/C2/1 wherein the dotted line in ring A denotes the optional presence of double bonds, R1 represents a hydrogen atom or a methyl group, R2 represents two hydrogen atoms when a D 4 double bond is absent, or a hydrogen or chlorine atom or a hydroxyl group when a D 4 double bond is present, R3 represents a hydrogen atom or an alkyl group preferably having less than six carbon atoms, R4 represents two hydrogen atoms or one hydrogen atom with an a -methyl group, and X represents a chlorine atom or the group -OR in which R represents an alkyl, alkenyl, cycloalkyl, aryl, halo-substituted aryl, aralkyl, alkaryl, alkoxyaryl, aryloxy alkyl or heterocyclic radical. The compounds may be prepared by direct acylation of a steroid compound having a hydroxy group in the 17b position with chlorosulphonylacetyl chloride in an inert solvent to give the sulphonyl chloride. The sulphonate esters may be prepared by reaction of the sulphonyl chloride so produced with an alcohol or directly by addition of an alcohol during the acylation. The sulphoacetates may be prepared from 3,17-androstenediones by protecting the D 4-3-keto position, reducing the 17-keto group and reacting with chlorosulphonyl acetyl chloride. Esters of testosterone-17-sulphoacetate may be prepared by treating testosterone with a Grignard reagent and reacting the resulting 17-halomagnesium compound with chlorosulphonylacetyl chloride and an alcohol. Therapeutic compositions with anabolic and androgenic properties, in the form of oil solutions or aqueous suspensions for parenteral administration, contain esters of androstaneand estrane-17-sulphoacetates of the above general formula.
机译:本发明包含式的化合物,其中环A中的虚线表示双键的任选存在,R 1代表氢原子或甲基,R 2代表两个氢原子,当D 4时当存在D 4双键时,不存在双键或氢或氯原子或羟基,R 3代表氢原子或优选具有少于六个碳原子的烷基,R 4代表两个氢原子或一个氢原子具有一个-甲基,且X代表一个氯原子或一个-OR基团,其中R代表一个烷基,烯基,环烷基,芳基,卤代芳基,芳烷基,烷芳基,烷氧基芳基,芳氧基烷基或杂环基。可以通过在惰性溶剂中用氯磺酰乙酰氯将在17b位具有羟基的甾族化合物直接酰化得到磺酰氯来制备化合物。磺酸酯可以通过将如此产生的磺酰氯与醇反应或通过在酰化过程中直接添加醇来制备。可以通过保护D 4-3-酮位,还原17-酮基并与氯磺酰基乙酰氯反应,由3,17-雄烯二酮制备磺基乙酸酯。可以通过用格氏试剂处理睾酮并使所得的17-卤代镁化合物与氯磺酰基乙酰氯和醇反应来制备17-磺基乙酸睾酮的酯。具有用于肠胃外给药的油溶液或水性悬浮液形式的具有合成代谢和雄激素特性的治疗组合物,包含上述通式的雄甾烷酸酯和雌二醇-17-磺基乙酸酯。

著录项

  • 公开/公告号DE1225637B

    专利类型

  • 公开/公告日1966-09-29

    原文格式PDF

  • 申请/专利权人 NOVO TERAPEUTISK LABOR AS;

    申请/专利号DE1964N024485

  • 发明设计人 BORREVANG POUL;

    申请日1964-02-21

  • 分类号A61K31/565;A61K31/568;C07J1/00;C07J31/00;C07J75/00;

  • 国家 DE

  • 入库时间 2022-08-23 14:59:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号